1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in ... Fibromyalgia, 2022, Munipalli et al

Discussion in ''Conditions related to ME/CFS' news and research' started by Andy, Aug 9, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    21,914
    Location:
    Hampshire, UK
    Abstract

    Objective
    To assess the association between vitamin B12 (B12) deficiency and the prevalence of fatigue and prespecified neurologic symptoms in patients with fibromyalgia.

    Patients and Methods
    A retrospective chart analysis of patients diagnosed with fibromyalgia in the years 2015-2020 was performed. The values of B12 were collected. The chart reviews assessed reported fatigue and neurologic symptoms, including brain fog, memory loss, cognitive impairment, paresthesias, numbness, and tingling, to assess their correlation with B12 levels. Concurrent vitamin D and thyroid-stimulating hormone levels were reviewed to assess their association with fibromyalgia.

    Results
    A total of 2142 patients with fibromyalgia with documented levels of B12 and vitamin D were included. Of them, 42.4% had B12 deficiency (<400 ng/L). Fatigue and memory loss were more common in the B12 deficiency group. After adjusting for vitamin D levels, B12 deficiency remained statistically significantly associated with the presence of fatigue (odds ratio, 1.39; 95% confidence interval, 1.11-1.75; P=.004).

    Conclusion
    This is the first study to report the association of B12 in patients with fibromyalgia complaining of fatigue. This symptom was prevalent in our group of patients with fibromyalgia with B12 deficiency, regardless of whether the cutoff point was 400 or 350 ng/L.

    Open access, https://www.mcpiqojournal.org/article/S2542-4548(22)00044-3/fulltext
     
    Hutan, Sarah Restieaux and Trish like this.
  2. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,597
    Interesting that they've used <400 ng/L as a threshold for deficiency, that is much higher than the lower reference points seen in Norway at least (I've seen the lowest points lie between 140-170 pmol/L, equivalent to 190-230 ng/L). I wonder how the results had been if these lower thresholds had been used (they also looked at symptoms when deficiency was set to <350 ng/L, but that is still higher than the lowest point of the reference ranges I'm familiar with).

    My guess is that the differences in symptoms would have been less noticeable, as there would be more patients defined as not deficient that also had fatigue. The threshold value of 400 ng is also above what I've seen argued as a safe point for subclinical B12 deficiency, so I wonder if there might be something else going on than lack of B12 being the problem. B12 is found in animal sourced foods that contribute a lot of other important nutrients to the body, those with a lower B12 concentration could be getting less of these nutrients.

    And obviously also a lot of other things ;)
     
    Michelle, alktipping, Hutan and 4 others like this.
  3. shak8

    shak8 Senior Member (Voting Rights)

    Messages:
    2,219
    Location:
    California
    They used retroactively patients who already had those lab tested done (Vit D and B12). Could that fact limit the uselfulness of the study?

    It could be that those lab tests were ordered precisely because the patients had outstanding (more than the usual per FM) symptoms pointing to Vit D and B12 deficiency?
     
  4. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,597
    The paper says: The values most closely associated with the date of the documentation of fibromyalgia were used in this study.

    So it is possible, depending on how often these tests are run where the study was performed. They are using their own facility's cutoff for deficiency, which may be different than whatever institution that actually analysed the patient's blood, that might also give some weird results as reference ranges differ between labs for a reason.
     
    Michelle, alktipping, Hutan and 2 others like this.
  5. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,856
    Location:
    Aotearoa New Zealand
    B12 levels were a good thing to look at in a big fibromyalgia population, but the results aren't very impressive. The symptoms of fatigue, memory loss, brain fog, cognitive impairment numbness and neuropathy were not very well correlated with B12 levels, if at all. The 350 ng/L level was specifically identified as giving the best prediction of fatigue (i.e. it wasn't decided before), and even then only 19.8% of people with less than 350 had fatigue, while 15.7% of people with more than 350 had fatigue. That's a result that sounds a lot like chance. The results suggests that, especially considering the potential selection bias for testing that @shak8 mentioned, fatigue associated with fibromyalgia isn't primarily caused by low B12.

    They didn't provide a straightforward scatter graph of B12 levels; I wish investigators would just present their base data in that way before adjusting for this and that.
     

Share This Page